BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Fibrogen

Below is an extended Fibrogen research listing. Click here to return to the Fibrogen main Biocorporate entry.

Recent Publications by Fibrogen:

CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy.
In diabetic nephropathy, connective tissue growth factor (CTGF) is...
18th July, 2008
Departments of *Pathology and Nephrology, University Medical Center J Am Soc Nephrol. 2008 Jul 16.
DOI Direct Link
The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
In order to fulfill its function of producing and delivering sufficient...
13th May, 2008
FibroGen, Inc., 225 Gateway Boulevard, South San Francisco, CA 94080, USA, J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):181-94. Epub 2008 May 10.
DOI Direct Link
Site-specific polymer modification of therapeutic proteins.
Recent advances in chemoselective ligation technology have made possible...
14th February, 2006
Gryphon Therapeutics, South San Francisco, CA 94080, USA. Curr Opin Chem Biol. 2005 Dec;9(6):555-60. Epub 2005 Oct 17.
DOI Direct Link
Recombinant microbial systems for the production of human collagen and gelatin.
The use of genetically engineered microorganisms is a cost-effective,...
10th February, 2006
FibroGen, Inc., 225 Gateway Boulevard, South San Francisco, CA 94080, USA. Appl Microbiol Biotechnol. 2005 Dec;69(3):245-52. Epub 2005 Nov 15.
DOI Direct Link
Expression and characterization of a low molecular weight recombinant human gelatin: development of a substitute for animal-derived gelatin with superior features.
Gelatin is used as a stabilizer in several vaccines. Allergic reactions to...
1st July, 2005
FibroGen, Inc. 225 Gateway Boulevard, South San Francisco, CA 94080, USA. Protein Expr Purif. 2005 Apr;40(2):346-57.
DOI Direct Link
Development of a recombinant human collagen-type III based hemostat.
Animal-tissue-derived collagen, containing mostly type I collagen with a...
16th December, 2004
Fibrogen, Inc., South San Francisco, California 94080, USA. J Biomed Mater Res B Appl Biomater. 2004 Apr 15;69(1):18-24.
DOI Direct Link
The application of recombinant human collagen in tissue engineering.
Collagen is the main structural protein in vertebrates. It plays an...
30th June, 2004
FibroGen Inc., 225 Gateway Boulevard, South San Francisco, CA 94080, USA. BioDrugs. 2004;18(2):103-19.
Recombinant collagen and gelatin for drug delivery.
The tools of recombinant protein expression are now being used to provide...
20th May, 2004
FibroGen, Inc., 225 Gateway Boulevard, South San Francisco, CA 94080, USA. Adv Drug Deliv Rev. 2003 Nov 28;55(12):1547-67.
Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts.
In skin, the profibrotic protein connective tissue growth factor (CTGF) is...
4th July, 2003
Fibrogen, Inc., South San Francisco, California 94080, USA. J Biol Chem. 2003 Apr 11;278(15):13008-15. Epub 2003 Feb 5.
DOI Direct Link
CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
BACKGROUND: The induction of excess matrix in renal fibrosis seems to be...
26th February, 2003
FibroGen, Inc., 225 Gateway Boulevard, South San Francisco, CA 94080, USA. Kidney Int. 2002 Oct;62(4):1149-59.
DOI Direct Link

«Fibrogen

This page contained an extended Fibrogen research listing. Click here to return to the Fibrogen main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.